Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-12-04

Clinical Trial Update: Pilot, Opened, Randomized Clinical Trial to Assess the Efficacy of Duloxetine in the Treatment of Fibromialgy in Patients With Infection by HIV 1+ [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial evaluated duloxetine for fibromyalgia in patients with HIV-1 infection; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Duloxetine (DULOXETINE)

Snippet

Sponsor: Germans Trias i Pujol Hospital | Conditions: Fibromyalgia, HIV-1 Infection | Phase 3 | Status: COMPLETED